Physician profile
Larry Mitchell
NPI 1760473102
$920.58
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $336 · 2021: $165 · 2022: $16.33 · 2023: $21.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $195.50 | 2019-2021 | |
| Novo Nordisk INC | $111.97 | 2019-2022 | |
| Amarin Pharma, INC. | $100.60 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $74.14 | 2019-2023 | |
| Allergan, INC. | $72.06 | 2019-2020 | |
| Lilly USA, LLC | $62.34 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $40.67 | 2019-2020 | |
| Astellas Pharma US INC | $35.78 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $32.66 | 2021 | |
| Abbvie INC. | $28.40 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $23.79 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.26 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.68 | 2021 | |
| Pfizer INC. | $17.11 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.71 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.34 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.49 | 2021 | |
| Glaxosmithkline, LLC. | $11.59 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.38 | 2020 | |
| Merck Sharp & Dohme LLC | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.